Cas no 1622217-20-2 (2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester)
2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester Chemical and Physical Properties
Names and Identifiers
-
- 2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester
- Methyl 2-fluoro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxylate
- 6-Fluoro-5-(methoxycarbonyl)pyridine-3-boronic acid pinacol ester
- 3-Pyridinecarboxylic acid, 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester
- Methyl 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate
- methyl 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxylate
- EN300-7384444
- Methyl2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate
- BS-31155
- XPC21720
- C13H17BFNO4
- CS-0175561
- AT14303
- 1622217-20-2
-
- MDL: MFCD18723851
- Inchi: 1S/C13H17BFNO4/c1-12(2)13(3,4)20-14(19-12)8-6-9(11(17)18-5)10(15)16-7-8/h6-7H,1-5H3
- InChI Key: WSPHCRVNJOWFOY-UHFFFAOYSA-N
- SMILES: C1(F)=NC=C(B2OC(C)(C)C(C)(C)O2)C=C1C(OC)=O
Computed Properties
- Exact Mass: 281.123
- Monoisotopic Mass: 281.123
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 20
- Rotatable Bond Count: 3
- Complexity: 375
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 57.6A^2
2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM210747-1g |
Methyl 2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate |
1622217-20-2 | 96% | 1g |
$171 | 2021-08-04 | |
| Chemenu | CM210747-5g |
Methyl 2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate |
1622217-20-2 | 96% | 5g |
$511 | 2021-08-04 | |
| TRC | F402953-10mg |
2-Fluoro-3-(Methoxycarbonyl)Pyridin-5-Ylboronic Acid Pinacol Ester |
1622217-20-2 | 10mg |
$ 50.00 | 2022-06-05 | ||
| TRC | F402953-50mg |
2-Fluoro-3-(Methoxycarbonyl)Pyridin-5-Ylboronic Acid Pinacol Ester |
1622217-20-2 | 50mg |
$ 135.00 | 2022-06-05 | ||
| TRC | F402953-100mg |
2-Fluoro-3-(Methoxycarbonyl)Pyridin-5-Ylboronic Acid Pinacol Ester |
1622217-20-2 | 100mg |
$ 230.00 | 2022-06-05 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | F14376-250mg |
2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester |
1622217-20-2 | > 97% | 250mg |
2605.0CNY | 2021-07-13 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | F14376-1g |
2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester |
1622217-20-2 | > 97% | 1g |
7802.0CNY | 2021-07-13 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | F14376-250mg |
2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester |
1622217-20-2 | > 97% | 250mg |
2605CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | F14376-1g |
2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester |
1622217-20-2 | > 97% | 1g |
7802CNY | 2021-05-08 | |
| Chemenu | CM210747-1g |
Methyl 2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate |
1622217-20-2 | 96% | 1g |
$171 | 2022-09-02 |
2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester Related Literature
-
H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
-
Yingbo Li,Nada Mehio,Huizhou Liu,Sheng Dai Green Chem., 2015,17, 2981-2993
-
Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
-
Ying Li,Weirong Yao,Yunfei Xie,Renjun Pei RSC Adv., 2015,5, 98724-98729
Additional information on 2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester
Introduction to 2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester (CAS No. 1622217-20-2)
2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester, identified by its CAS number 1622217-20-2, is a specialized organoboron compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This boronic acid ester derivative features a pyridine core substituted with a fluoro group at the 2-position and a methoxycarbonyl (ester) group at the 3-position, further protected as a pinacol ester at the boronic acid functionality. Such structural motifs are particularly valuable due to their potential in cross-coupling reactions, which are pivotal in the synthesis of complex organic molecules, including drug candidates.
The compound’s utility stems from its reactivity in Suzuki-Miyaura cross-coupling reactions, a cornerstone of modern synthetic organic chemistry. The presence of the boronic acid pinacol ester not only facilitates compatibility with palladium-catalyzed reactions but also enhances stability during storage and handling. This makes 2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester an attractive building block for constructing biaryl frameworks, which are prevalent in many biologically active compounds.
In recent years, there has been a surge in research focused on fluorinated pyridines due to their unique electronic properties and their ability to modulate metabolic stability and binding affinity in drug molecules. The fluorine atom at the 2-position of the pyridine ring in this compound imparts lipophilicity and can influence the pharmacokinetic profile of derivatives. Furthermore, the methoxycarbonyl group provides additional versatility, allowing for subsequent functionalization via hydrolysis or reduction to yield more reactive intermediates.
Current studies highlight the role of such boronic acid esters in the development of novel therapeutic agents. For instance, researchers have explored derivatives of this compound in the synthesis of kinase inhibitors, where precise control over molecular architecture is crucial for achieving high selectivity and potency. The pinacol ester protecting group ensures that the boronic acid functionality remains inert under non-reductive conditions, enabling selective activation when required.
The pharmaceutical industry has increasingly relied on transition-metal-catalyzed cross-coupling reactions to streamline drug discovery processes. 2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester serves as an excellent precursor for generating libraries of substituted pyridines, which can then be screened for biological activity. Its incorporation into fragment-based drug design strategies has shown promise in identifying lead compounds with favorable pharmacological properties.
From a synthetic chemistry perspective, this compound exemplifies the importance of boronic acids in modern drug development. The ability to introduce complex aryl groups with high regioselectivity is a testament to the power of organoboron chemistry. As synthetic methodologies continue to evolve, compounds like 2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester will remain indispensable tools for medicinal chemists seeking to innovate at the molecular level.
Moreover, advancements in flow chemistry have enabled more efficient and scalable preparations of such boronic esters, reducing reliance on traditional batch processes. This shift toward continuous manufacturing not only improves yield but also enhances safety by minimizing solvent exposure. The stability and reactivity profile of CAS No. 1622217-20-2 make it an ideal candidate for these emerging technologies.
The broader impact of this compound on drug discovery cannot be overstated. Its role in facilitating rapid diversification of molecular structures has accelerated the pace at which new candidates enter clinical trials. As regulatory pressures demand faster development cycles, compounds that enable efficient synthetic routes—such as 2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester—will continue to be integral to pharmaceutical innovation.
In conclusion, CAS No. 1622217-20-2 represents a critical component in contemporary synthetic organic chemistry, particularly within medicinal chemistry applications. Its unique structural features and reactivity make it a valuable reagent for constructing novel therapeutic agents. As research progresses, its utility is expected to expand further, driven by both technological advancements and unmet medical needs.
1622217-20-2 (2-Fluoro-3-(methoxycarbonyl)pyridin-5-ylboronic acid pinacol ester) Related Products
- 957198-26-4(5-(4,4,5-trimethyl-1,3,2-dioxaborolan-2-yl)-3-Pyridinecarboxylic acid ethyl ester)
- 1622217-36-0(methyl 6-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxylate)
- 2605229-03-4(3-Pyridinecarboxylic acid, 5-(4,4,5-trimethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester)
- 1333319-63-3(2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinaldehyde)
- 1025718-91-5(methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxylate)
- 1309982-38-4(tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate)
- 916326-10-8(ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxylate)
- 2225178-29-8(6-fluoro-5-(methoxycarbonyl)pyridin-3-ylboronic acid)
- 1150561-71-9(2-fluoro-3-methylpyridine-5-boronic acid pinacol ester)
- 2377606-46-5(5-borononicotinic acid pinacol ester)